Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome
- PMID: 14623934
- DOI: 10.1177/002215540305101210
Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome
Abstract
Germline mutations of the LKB1 gene lead to Peutz-Jeghers syndrome (PJS), which is associated with a predisposition to gastrointestinal polyposis and cancer. In this study we tested for germline mutations of LKB1 in 11 patients with PJS from nine families and analyzed the expression patterns of the LKB1 and cyclo-oxygenase-2 (COX-2) proteins in 28 Peutz-Jeghers polyps (PJPs) and five carcinomas from these patients by immunohistochemical (IHC) analysis. In eight of those families we identified seven different mutations, which consisted of two splice site mutations, two nonsense mutations, one small in-frame deletion, one frame-shift mutation, and one silent mutation. Immunostaining revealed nuclear and cytoplasmic expression of LKB1 protein in 23 PJPs and five carcinomas, nuclear expression alone in one PJP, and loss of LKB1 protein expression in four PJPs, indicating a heterogeneous LKB1 expression pattern in PJPs. Overexpression of COX-2 was detected in 23 (82%) of 28 PJPs and in all carcinomas. Despite heterogeneity in staining of LKB1 among individuals and even among samples from the same individual, we found statistically significant correlations in staining of LKB1 relative to COX-2. These results suggest that COX-2 plays a role in tumorigenesis in PJS and may therefore be considered as a potential target for PJS chemoprevention.
Similar articles
-
Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity.J Clin Pathol. 2007 Apr;60(4):392-6. doi: 10.1136/jcp.2005.036418. Epub 2006 Jun 14. J Clin Pathol. 2007. PMID: 16775120 Free PMC article.
-
Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome.J Clin Pathol. 2001 Feb;54(2):126-31. doi: 10.1136/jcp.54.2.126. J Clin Pathol. 2001. PMID: 11215281 Free PMC article.
-
Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis.Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12327-32. doi: 10.1073/pnas.192301399. Epub 2002 Sep 6. Proc Natl Acad Sci U S A. 2002. PMID: 12218179 Free PMC article.
-
[Peutz-Jeghers syndrome].Nihon Rinsho. 2000 Jul;58(7):1400-4. Nihon Rinsho. 2000. PMID: 10921312 Review. Japanese.
-
Mutations in the human LKB1/STK11 gene.Hum Mutat. 2005 Oct;26(4):291-7. doi: 10.1002/humu.20222. Hum Mutat. 2005. PMID: 16110486 Review.
Cited by
-
Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.Cancer Lett. 2009 May 18;277(2):149-54. doi: 10.1016/j.canlet.2008.11.036. Epub 2009 Jan 14. Cancer Lett. 2009. PMID: 19147279 Free PMC article.
-
Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.Mol Genet Genomics. 2005 Apr;273(2):184-96. doi: 10.1007/s00438-005-1124-y. Epub 2005 Feb 25. Mol Genet Genomics. 2005. PMID: 15731909
-
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.Breast Cancer Res. 2012 Feb 21;14(1):R35. doi: 10.1186/bcr3128. Breast Cancer Res. 2012. PMID: 22353783 Free PMC article.
-
Targeting the LKB1 tumor suppressor.Curr Drug Targets. 2014 Jan;15(1):32-52. doi: 10.2174/1389450114666140106095811. Curr Drug Targets. 2014. PMID: 24387336 Free PMC article. Review.
-
Genotype-phenotype correlations in Peutz-Jeghers syndrome.J Med Genet. 2004 May;41(5):327-33. doi: 10.1136/jmg.2003.010900. J Med Genet. 2004. PMID: 15121768 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials